NCT00842270View on ClinicalTrials.gov

Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Conditions
Asthma
Interventions
DRUG

AB1010

3 mg/kg/day

DRUG

AB1010

4,5 mg/kg/day

DRUG

AB1010

6 mg/kg/day

DRUG

placebo

matching placebo to AB1010 dosages

Sponsors

Lead Sponsor

AB Science
All Listed Sponsors
lead

AB Science

INDUSTRY